In the North American health care setting, there is increasing recognition of the importance of providing inclusive comprehensive care to transgender, gender-diverse, and nonbinary (TGDNB) peoples.^[@B1]^ Transgender is a term used to describe individuals who experience their gender identity differently from the sex they were assigned at birth.^[@B4]^ Accurate representation of their gender identity within health records continues to be a challenge for TGDNB peoples as the health care community struggles to use inclusive terminology in medicine.^[@B5]^

It has been \>25 years since the Canadian McInerney v. MacDonald (1992) case established that patients have the right to access information contained in their health records, and in the United States, the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule enfranchises those same rights.^[@B6],[@B7]^ With ongoing health care advances, medical documentation has dramatically changed from hand-written notes to online documentation. These electronic medical records (EMRs) serve to digitally immortalize patient\'s health histories and health care.

Over the past two decades, health care in North America has moved toward a person-centered model. As a result of this movement, the availability of patient-accessible EMRs has increased considerably. Enhanced patient access to their personal health information supports shared decision-making, improves communication with health care providers, and allows for any concerns or inaccuracies to be corrected in the record---necessitating thoughtful consideration to inclusive medical language used within patient EMRs.^[@B8],[@B9]^

Readily available EMR information removes the added barrier of formally requesting copies of health record reports and supports self-management by promoting health care knowledge and awareness.^[@B10]^ Access to health information drives patient convenience, strengthens patient--provider communication, and increases feelings of empowerment over one\'s agency of care.^[@B11],[@B12]^ When patients access their EMRs, laboratory results, including pathology reports, are among the most frequently viewed items.^[@B13],[@B14]^ In an oncological setting, for instance, the pathology report is an important source of information regarding diagnoses, treatment, and prognoses.

As part of a process referred to as gender transition, transgender people often seek medical care, including hormone therapy or surgery, to instigate changes in their secondary sex characteristics that more closely approximate the gender with which they self-identify.^[@B5]^ Gender-affirming surgical procedures include, but are not limited to, penectomy, orchiectomy, reduction thyrochondroplasty, total hysterectomy with bilateral salpingo-oophorectomy, and bilateral total reduction mammoplasty, all of which can result in surgical specimens requiring pathology reports.

Pathology reports have traditionally functioned as a communication tool solely between physicians; however, EMRs containing pathology results serve as an opportunity to optimize communication for transgender individuals, thereby alleviating the stress and stigma associated with viewing their health care record. Although these procedures rarely result in concerning pathological findings, the advent of patient-accessible pathology reports places a greater onus on the pathologist to use appropriate and objective language, particularly for transgender patients.

Within laboratory medicine, there has been limited discussion of its role in providing and optimizing transgender care. Gupta et al. described the lack of standardization of laboratory reference values in hematology and biochemistry and the difficulty in assessing screening tests, such as Pap smears, in transitioned individuals.^[@B15]^ They also remarked on the challenge of assessing biopsy specimens that may be influenced by exogenous hormones, such as prostate or breast tissue; however, they did not elaborate on the appropriate terminology for surgical sign out. Imborek et al. also noted the challenges of interpreting laboratory tests after transition; however, this group further explored challenges within laboratory medicine that comes from the incorporation of preferred name and gender identity, such as regulations regarding blood donor eligibility criteria in transfusion medicine and institutional barriers to specimen labeling with preferred names.^[@B16]^

It is well established that transgender patients often report acute discomfort when addressed according to a gender that is discordant with the gender with which they self-identify and it is for this reason that EMRs are increasingly incorporating gender identity data.^[@B17]^ Pathology reports that include gendered language such as "female breast tissue" rather than utilizing objective language such as "breast tissue with terminal duct lobular units" create a health care barrier in the form of disenfranchising the patient and adding to the lived reality of discrimination and harassment faced by trans individuals.^[@B20]^

To best serve transgender patients while maintaining a high standard of diagnostic integrity, we propose a set of inclusive terminology to be utilized in pathology reports for gender-affirming surgery (see [Table 1](#T1){ref-type="table"}). We outline terminology for tissue that has no histopathological abnormality as well as tissue that demonstrates changes associated with exogenous hormones. In [Table 2](#T2){ref-type="table"}, we further outline best practices in pathology reporting for transgender patients as well as clarifying pathology report items that should or should not be included within the pathology report.

###### 

Suggested Terminology for Anatomical Pathology Reporting for Gender-Affirming Surgery

  Specimen/procedure                                                                      Suggested diagnosis (No exogenous hormone exposure)           Suggested diagnosis (Exogenous hormone exposure)                                      Discouraged terminology
  --------------------------------------------------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------------------------------- -------------------------
  Orchiectomy                                                                             Benign testicular tissue or parenchyma                        Benign testicular tissue with changes consistent with exogenous hormone exposure      Male testicular tissue
  Testicular atrophy                                                                      "Feminization" of testicular tissue                                                                                                                 
  Decreased spermatogenesis                                                                                                                                                                                                                   
  Hypospermatogenesis                                                                                                                                                                                                                         
  Maturation arrest                                                                                                                                                                                                                           
  Germ cell aplasia                                                                                                                                                                                                                           
  Penectomy                                                                               Benign penile tissue or parenchyma                            No findings expected                                                                   
  Hysterectomy                                                                            Benign endomyometrium tissue or parenchyma                    Benign endometrium with changes consistent with exogenous hormone exposure             
  Inactive endometrium                                                                                                                                                                                                                        
  Salpingectomy                                                                           Benign fallopian tube tissue or parenchyma                    No findings expected                                                                   
  Oophorectomy                                                                            Benign ovarian tissue or parenchyma                           Benign ovarian tissue with changes consistent with exogenous hormone administration    
  Benign ovarian tissue with histological changes mimicking polycystic ovarian syndrome                                                                                                                                                       
  Mastectomy                                                                              Benign breast tissue                                          Benign breast tissue with changes consistent with exogenous hormone exposure          Female breast tissue
  Benign mammary tissue                                                                   Breast tissue with terminal duct units with lobular atrophy   Male breast tissue                                                                    
  Benign fibroadipose tissue with terminal duct lobular units                             Masculinization of breast tissue                                                                                                                    
  Gynecomastia (in the context of exogenous androgen exposure)                                                                                                                                                                                

###### 

Reporting of Gender-Affirming Surgical Procedures in the Anatomical Pathology

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  When describing the procedure, do include the technical name for the surgery.
   Penectomy
   Orchiectomy
   Hysterectomy (total, subtotal/supracervical)
   Oophorectomy
   Salpingectomy
   Mastectomy
  When describing the procedure, as with all other pathology reporting, the reason for performing the surgery is not required. If, as a pathologist, you believe there is a medically necessary reason to include the rationale, the most appropriate term is "gender affirmation" or "gender-affirming" surgery.
  In particular, the following terminology should be avoided in pathology reports:
   Gender reassignment
   Sex reassignment
   Gender dysphoria treatment/reversal/therapy
  Do highlight the presence or absence of tissue within the surgical specimen that may have future cancer screening or diagnostic consequences.^[@B22; @B23; @B24]^
  Examples include:
   Presence of exocervix in hysterectomy specimens
   Completeness and bilaterality of fallopian tubes in salpingectomy specimens
   Bilaterality of ovaries in oophorectomy specimens
  While the prostate is seldom removed in gender affirmation surgery, its presence and completeness should be noted.
  Any pathology present in a gender-affirming surgical specimen should be appropriately reported.
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

It will require infrastructural changes in EMRs and the institution of appropriate medical education to appropriately remove unnecessary gendered terms from pathology reports.^[@B18]^ Budding efforts toward integrating transgender health care training into medical curricula at the undergraduate and postgraduate levels are emerging but progress remains nascent.^[@B21]^ To further overcome transgender populations\' experience of health inequities, additional training opportunities should be made available to practicing pathologists to help longitudinally integrate gender-neutral and nonexclusionary transgender language into EMRs through the surgical sign out. By keeping the specimen-naming and diagnostic line items objective, we further uphold the crux of professionalism and leadership in pathology, serve our transgender patients, and lead by example as the "Doctor\'s doctor."
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